[1]
|
M. Y. Wang, B. J. West, C. J. Jensen, D. Nowicki, C. Su, A. K. Palu and G. Anderson, “Morinda Citrifolia (Noni): A Literature Review and Recent Advances in Noni Research,” Acta Pharmacological Sinica, Vol. 23, No. 12, 2002, pp. 1127-1141.
|
[2]
|
S. L. T. Palu, “A Traditional Healer from ‘Uiha, Ha’apai, Tonga, South Pacific,” Personal Communication, Orem, 2004.
|
[3]
|
A. P. Benthall, “The Trees of Calcutta and Its Neighborhood,” Spink, Calcutta, 1984.
|
[4]
|
V. A. Palepale, “A Traditional Healer from Ha’alalo, Tonga, South Pacific,” Personal Communication, Lehi, 2005.
|
[5]
|
J. J. Wadsworth and S. P. Story, “Morinda citrifolia Oil,” US Patent No. 6417157, 2002.
|
[6]
|
S. C. Nelson, “Hawaiian Noni Seed Processing and Germination,” 2005.
http://www.ctahr.hawaii.edu/noni/downloads/noniseeds.pdf
|
[7]
|
A. M. Kligman, “The Identification of Contact Allergens by Human Assay. III. The Maximization Test: A Procedure for Screening and Rating Contact Sensitizers,” TheJournal of Investigative Dermatology, Vol. 47, No.5, 1966, pp. 393-409.
|
[8]
|
R. L. Rietschel and J. F. Fowler, “Fisher’s Contact Dermatitis,” 4th Edition, Williams & Wilkins, Baltimore, 1995.
|
[9]
|
O. H. Mills and A. M. Kligman, “The Follicular Biopsy,” Dermatologica, Vol. 167, No. 2, 1983, pp. 57-63.
|
[10]
|
T. D. Warner, F. Giuliano, I. Vojnovic, A. Bukasa, J. A. Mitchell and J. R. Vane, “Nonsteroid Drug Selectivities for Cyclo-Oxygenase-1 rather than Cyclo-Oxygenase-2 Are Associated with Human Gastrointestinal Toxicity: A Full in Vitro Analysis,” Proceedings of the National Academy of Sciences of the USA, Vol. 96 No. 13, 1999, pp. 7563-7568. doi:10.1073/pnas.96.13.7563
|
[11]
|
D. Riendeau, S. Charleson, W. Cromlish, J. A. Mancini, E. Wong and J. Guay, “Comparison of the Cyclooxygenase-1 Inhibitory Properties of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Selective COX-2 Inhibitors, Using Sensitive Microsomal and Platelet Assays,” Canadian Journal of Physiology and Pharmacology, Vol. 75, No. 9, 1997, pp. 1088-1095.
doi:10.1139/y97-130
|
[12]
|
G. W. Carter, P. R. Young, D. H. Albert, J. Bouska, R. Dyer, R. L. Bell, J. B. Summers and D. W. Brooks, “5-Lipoxygenase Inhibitory Activity of Zileuton,” The Journal of Pharmacology and Experimental Therapeutics, Vol. 256, No. 3, 1991, pp. 929-937.
|
[13]
|
H. Safayhi, S. E. Boden, S. Schweizer and H. P. Ammon, “Concentration-Dependent Potentiating and Inhibitory Effects of Boswellia Extracts on 5-Lipoxygenase Product Formation in Stimulated PMNL,” Planta Medica, Vol. 66, No. 2, 2000, pp. 110-113. doi:10.1055/s-2000-11136
|
[14]
|
B. J. West, C. J. Jensen and J. Westendorf, “A New Vegetable Oil from Noni (Morinda citrifolia) Seeds,” International Journal of Food Science and Technology, Vol. 43, No. 11, 2008, pp. 1988-1992.
doi:10.1111/j.1365-2621.2008.01802.x
|
[15]
|
P. Rubin and K. W. Mollison, “Pharmacotherapy of Diseases Mediated by 5-Lipoxygenase Pathway Eicosanoids,” Prostaglandins & Other Lipid Mediators, Vol. 83, No. 3, 2007, pp. 188-197.
doi:10.1016/j.prostaglandins.2007.01.005
|
[16]
|
I. Kurokawa, F. W. Danby, Q. Ju, X. Wang, L. F. Xiang, L. Xia, W. Chen, I. Nagy, M. Picardo, D. H. Suh, R. Ganceviciene, S. Schagen, F. Tsatsou and C. C. Zouboulis, “New Developments in Our Understanding of Acne Pathogenesis and Treatment,” Experimental Dermatology, Vol. 18, No. 10, 2009, pp. 821-832.
doi:10.1111/j.1600-0625.2009.00890.x
|
[17]
|
J. J. F. Belch and A. Hill, “Evening Primrose Oil and Borage Oil in Rheumatologic Conditions,” American Journal of Clinical Nutrition, Vol. 71, No. 1, 2000, pp. 352-356.
|
[18]
|
C. Letawe, M. Boone and G. E. Pierard, “Digital Image Analysis of the Effects of Topically Applied Linoleic Acid on Acne Micro-Comedones,” Clinical and Experimental Dermatology, Vol. 23, No. 2, 1998, pp. 56-58.
doi:10.1046/j.1365-2230.1998.00315.x
|
[19]
|
A. Klegeris and P. L. McGreer, “Cyclooxygenase and 5-Lipoxygenase Inhibitors Protect Against Mononuclear Phagocyte Neurotoxicity,” Neurobiology of Aging, Vol. 23, No. 5, 2002, pp. 787-794.
doi:10.1016/S0197-4580(02)00021-0
|
[20]
|
J. Pommery, N. Pommery and J. P. Henichart, “Modification of Eicosanoid Profile in Human Blood Treated by Dual COX/LOX Inhibitors,” Prostaglandins, Leukotrienes, and Essential Fatty Acids, Vol. 73, No. 6, 2005, pp. 411-417. doi:10.1016/j.plefa.2005.08.009
|
[21]
|
L. Goossens, N. Pommery and J. P. Henichart, “COX2/5-LOX Dual Acting Anti-Inflammatory Drugs in Cancer Chemotherapy,” Current Topics in Medicinal Chemistry, Vol. 7, No. 3, 2007, pp. 283-296.
doi:10.2174/156802607779941369
|
[22]
|
C. X. Su, “A New Selective COX-2 Inhibitor: Morinda citrifolia (Noni). Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Related Diseases,” 7th Annual Conference, Nashville, 14-17 October 2001.
|
[23]
|
A. K. Palu, C. Su, B. N. Zhou and J. Jensen, “Morinda citrifolia L.: A Dual Inhibitor of COX-2 and 5-LOX Enzymes,” 5th International Conference and Exhibition on Nutraceuticals and Functional Foods, San Francisco, 7-10 November 2004.
|
[24]
|
A. Valentino, M. Fimiani, R. Baiocchi, R. Bilenchi, R. Perotti, A. Castelli, M. L. Mancianti and M. Raffaelli, “Cosmetic Acne and a Test of Comedogenicity,” Bollettino Della Società Italiana di Biologia Sperimentale, Vol. 60, No. 10, 1984, pp. 1845-1848.
|
[25]
|
C. R. Srinivas, A. Padhee, C. Balanchandran, S. D. Shenoy, S. Acharya and K. Ramnaraya, “Comedones Induced by Coconut Oil in a Borderline Tuberculoid Lesion,” International Journal of Leprosy and Other Mycobacterial Diseases, Vol. 56, No. 3, 1988, pp. 471-472.
|
[26]
|
J. A. Menendez, L. R. Vellon, R. Colomer and R. Lupu, “Oleic Acid, the Main Monounsaturated Fatty Acid of Olive Oil, Suppresses Her-2/neu (erbB-2) Expression and Synergistically Enhances the Growth Inhibitory Effects of Trastuzumab (HerceptinTM) in Breast Cancer Cells with Her-2/neu Oncogene Amplification,” Annals of Oncology, Vol. 16, No. 3, 2005, pp. 359-371.
doi:10.1093/annonc/mdi090
|
[27]
|
V. M. Flood, K. L. Webb, E. Rochtchina, B. Kelly and P. Mitchell, “Fatty Acid Intakes and Food Sources in a Population of Older Australians,” Asia Pacific Journal of Clinical Nutrition, Vol. 16, No. 2, 2007, pp. 322-330.
|
[28]
|
G. Irmisch, D. Schlafke, W. Gierow, S. Herpertza and J. Richter, “Fatty Acids and Sleep in Depressed Inpatients,” Prostaglandins, Leukotrienes, and Essential Fatty Acids, Vol. 76, No. 1, 2007, pp. 1-7.
doi:10.1016/j.plefa.2006.09.001
|
[29]
|
C. D. Daulatabad, G. M. Mulla and A. M. Mirajkar, “Ricinoleic Acid in Morinda citrifolia Seed Oil,” Journal of Oil and Technologists Association, Vol. 21, No. 2, 1989, pp. 26-27.
|
[30]
|
A. Kogan and N. Garti, “Microemulsions as Transdermal Drug Delivery Vehicles,” Advanced Colloid and Interface Science, Vol. 123-126, 2006, pp. 369-385.
doi:10.1016/j.cis.2006.05.014
|
[31]
|
L. C. Zhang, J. H. Hu and L. Li, “In Vivo and in Vitro Evaluation of Essential Oils from Ligusticum chuanxiong HORT on the Transdermal Delivery of Flurbiprofen in Rabbits,” Biological & Pharmaceutical Bulletin, Vol. 29, No. 6, 2006, pp. 1217-1222. doi:10.1248/bpb.29.1217
|
[32]
|
R. Jantharaprapap and R. Stagni, “Effects of Penetration Enhancers on in Vitro Permeability of Meloxicam Gels,” International Journal of Pharmaceutics, Vol. 343, No. 1-2, 2007, pp. 26-33. doi:10.1016/j.ijpharm.2007.04.011
|
[33]
|
G. Martin-Ezquerra, M. Sanchez-Regana and P. UmbertMillet, “Optimization of Narrow-Band UVB with a 5% Oleic Acid Cream in the Treatment of Psoriasis,” Journal of Drugs in Dermatology, Vol. 6, No. 3, 2007, pp. 290-292.
|